WallStreetZenWallStreetZen

NASDAQ: JSPR
Jasper Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

JSPR earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$64.5M
Current Profit Margin
0%

JSPR Return on Equity

Current Company
-63.2%
Current Industry
-63.5%
Current Market
188%
JSPR's Return on Equity (-63.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when JSPR announces earnings.

JSPR Return on Assets

Current Company
-55.1%
Current Industry
2.9%
JSPR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

JSPR Return on Capital Employed

Current Company
-78.12%
Current Industry
19.5%
JSPR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

JSPR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
JSPR$0.00-$62.94M-$64.47MN/AN/A
MGTX$0.00-$57.05M-$84.03MN/AN/A
BDTX$0.00-$82.01M-$82.44MN/AN/A
NAUT$0.00-$57.97M-$63.68MN/AN/A
AVIR$0.00-$134.52M-$135.96M-100.00%N/A
View Top Biotech Stocks

JSPR earnings dates

Next earnings date
Jun 6, 2024

Jasper Therapeutics Earnings & Revenue FAQ

What were JSPR's earnings last quarter?

On Invalid Date, Jasper Therapeutics (NASDAQ: JSPR) reported Q4 2023 earnings per share (EPS) of -$1.48, up 59.23% year over year. Total Jasper Therapeutics earnings for the quarter were -$16.58 million. In the same quarter last year, Jasper Therapeutics's earnings per share (EPS) was -$3.63.

If you're new to stock investing, here's how to buy Jasper Therapeutics stock.

What was JSPR's earnings growth in the past year?

As of Q2 2024, Jasper Therapeutics's earnings has grown year over year. Jasper Therapeutics's earnings in the past year totalled -$64.47 million.

What is JSPR's earnings date?

Jasper Therapeutics's earnings date is Invalid Date. Add JSPR to your watchlist to be reminded of JSPR's next earnings announcement.

What was JSPR's revenue last quarter?

On Invalid Date, Jasper Therapeutics (NASDAQ: JSPR) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Jasper Therapeutics's revenue was $0.00.

What was JSPR's revenue growth in the past year?

As of Q2 2024, Jasper Therapeutics's revenue has grown null year over year. Jasper Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.